Science has studied people who came remarkably close to death, but the hardest question still remains beyond direct ...

Nearly one in three adults who were still smoking or vaping after a prior ORCA trial had quit at the end of a year of ...

In a deep, dark part of the Gulf of Mexico, the number of marine animals plummeted by about 60% in the years following the ...

Money from the world’s increasingly prosperous technology entrepreneurs has been flooding into biomedical research. Is it ...

CEOs of smaller ASX biotechs are paying the price of trial failures, regulatory setbacks and difficult capital markets in their ... Read More The post Biocurious: Lifting the lid on ASX life science ...

Anavex Life Sciences will proceed with a clinical study of a new drug to treat the genetic disorder Fragile X syndrome after getting clearance from U.S. regulators. The company said the Food and Drug ...

Inc., a privately held clinical-stage biopharmaceutical company developing next-generation therapies for retinal diseases, today announced positive topline results from its BETTIS-1 Phase 2 clinical ...

Stanford scientists have developed a revolutionary microscope that reveals the hidden inner workings of living cells in real ...

A tech-infused approach to learning the humanities is essential in a digital world. We focus on empowering you to be an agent, a player, a driver of change by giving you the tools to make a difference ...

Nobel-winning scientific breakthroughs have repeatedly emerged from organisms once considered too simple or too distant from human biology to be useful. Research on yeast revealed fundamental ...